Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-FR | Version v5-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2017-03-21 | 2017-03-21 |
| Drug Identification Number | 02182742 | 02182742 |
| Brand name | FLUOROURACIL INJECTION USP | FLUOROURACIL INJECTION USP |
| Common or Proper name | Fluorouracil (5FU) | Fluorouracil (5FU) |
| Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
| Ingredients | FLUOROURACIL | FLUOROURACIL |
| Strength(s) | 50MG | 50MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 5 g/100 mL x 1 | 5 g/100 mL x 1 |
| ATC code | L01BC | L01BC |
| ATC description | ANTIMETABOLITES | ANTIMETABOLITES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2017-03-02 | 2017-03-02 |
| Estimated end date | 2017-03-20 | 2017-03-20 |
| Actual end date | 2017-03-20 | 2017-03-20 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Released March 20, 2017 | Released March 20, 2017 |
| Health Canada comments |